OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide
OrthoPediatrics announced an exclusive distribution agreement with OSSIO to provide the OSSIOfiber bio-integrative fixation technology to children's hospitals across the U.S. The metal-free implants are designed to be replaced by natural bone during the healing process, potentially reducing the need for secondary hardware removal surgeries.
Key figures
- Total systems count
- 90
- Countries served count
- 75
- Integration period months
- 18–24
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.